Navigation Links
St. Jude Children's Research Hospital renewed as NCI-designated Comprehensive Cancer Center
Date:6/11/2014

(MEMPHIS, Tenn. June 11, 2014) St. Jude Children's Research Hospital's designation as a Comprehensive Cancer Center has been renewed by the National Cancer Institute (NCI), earning the highest possible score of "exceptional." St. Jude remains the first and only NCI-designated Comprehensive Cancer Center that is devoted solely to children. St. Jude has been designated as an NCI cancer center since 1977. The hospital was named a comprehensive cancer center in 2008.

A comprehensive cancer center must possess a deep and broad research-based portfolio that extends from the laboratory to the clinic and includes population-based science. Centers must also be actively engaged in professional and public cancer education and outreach.

"We are honored to once again receive this recognition, especially to receive a score of "exceptional"the highest the NCI awards to cancer centers," said Richard Gilbertson, M.D., Ph.D., St. Jude Comprehensive Cancer Center director. "St. Jude has been an NCI-designated cancer center for almost 40 years. Throughout this time, we have served as a national resource for children with cancer, their families and physicians. From the first pipette that's picked up in the lab to the last child treated in the clinic at the end of the day, everything is focused on our patients. We are driven by a common goal to find cures for all children with cancer."

"The efforts of our more than 160 clinicians and scientists are incredible," Gilbertson said. "During the last five years, we have made more than 32,500 patient enrollments to clinical studies. In the year prior to our NCI renewal, we ran 166 cancer clinical trials, including 36 brand new studies. In addition to the children we treat at St. Jude, we provide thousands of free patient consultations each year for children around the world. These are frequently complex and involve extensive histopathology, imaging and clinical chart reviews. In keeping with the ethos of St. Jude, no payment is requested for any consultation."

At St. Jude, the Comprehensive Cancer Center is organized as five cross-disciplinary, multi-departmental programs aligned to specific diseases and research conceptsDevelopmental Biology and Solid Tumor Program; Neurobiology and Brain Tumor Program; Hematological Malignancies Program; Cancer Prevention and Control Program; and the Cancer Genetics, Biochemistry and Cell Biology Program. The availability of 10 centralized shared resources with well-equipped facilities support the design, implementation, analysis, interpretation and reporting of research.

"The Comprehensive Cancer Center at St. Jude is at the very heart of our institution, bringing people together to accelerate science and facilitate the translation of discoveries from the laboratory to the clinic to develop innovative new treatments," said Dr. William E. Evans, St. Jude director and CEO. "To be given an 'exceptional' rating after such a comprehensive and rigorous peer-review process is truly meaningful and extremely gratifying."

"Spurred on by this honor from the NCI, the St. Jude Comprehensive Cancer Center is poised more than ever before to leverage our exciting discoveries and resources to bring new treatments and hope to all children with cancer," Gilbertson said.


'/>"/>

Contact: Carrie Strehlau
carrie.strehlau@stjude.org
901-595-2295
St. Jude Children's Research Hospital
Source:Eurekalert

Related medicine news :

1. CHOC researchers identify technique to reduce childrens post-op pain after high-risk surgery
2. Vibrant Nutraceuticals Announces Launch of Vegan Childrens’ Probiotic, KidsLac
3. Benaroya Research Institute scientists identify drivers of rheumatoid arthritis
4. Researchers uncover common heart drugs link to diabetes
5. EULAR driving research and innovation in rheumatic and RMDs in Europe
6. Mayo Clinic researchers discover new form of cancer
7. UCL licences research to Collagen Solutions for next generation collagen products
8. Researchers recast addiction as a manageable disease
9. Mount Sinai researchers identify protein that keeps blood stem cells healthy as they age
10. The Academy of Radiology Research featured in Nature Biotechnology journal
11. Berkeley Lab researchers create nanoparticle thin films that self-assemble in 1 minute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  In a startling report released today, National Safety ... lacking a comprehensive, proven plan to eliminate prescription opioid overdoses. ... how states are tackling the worst drug crisis in recorded U.S. ... Kentucky , New Mexico , ... Of the 28 failing states, three – Michigan ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... , June 23, 2016 , ... on Thursday, July 7, 2016 , , , , LOCATION: ... , , , , EXPERT PANELISTS:  , , , ... Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and ... The global pharmaceutical industry is witnessing an exceptional era. ...
Breaking Medicine Technology: